Related Experiment Video
Updated: Aug 5, 2026

Telomerase Activity in the Various Regions of Mouse Brain: Non-Radioactive Telomerase Repeat Amplification Protocol (TRAP) Assay
Published on: September 2, 2014
Arsenic inhibition of telomerase transcription leads to genetic instability
W C Chou1, A L Hawkins, J F Barrett
1Program in Human Genetics and Molecular Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract:
Arsenic is effective in the treatment of acute promyelocytic leukemia. Paradoxically, it is also carcinogenic. In the process of elucidating a mechanism of arsenic resistance in a leukemia cell line, NB4, we discovered that arsenic exposure causes chromosomal abnormalities, with a preponderance of end-to-end fusions. These chromosomal end fusions suggested that telomerase activity may be inhibited by arsenic. We found that arsenic inhibits transcription of the hTERT gene, which encodes the reverse transcriptase subunit of human telomerase. This effect may in part be explained by decreased c-Myc and Sp1 transcription factor activities. Decreased telomerase activity leads to chromosomal end lesions, which promote either genomic instability and carcinogenesis or cancer cell death. These phenomena may explain the seemingly paradoxical carcinogenic and antitumor effects of arsenic.
Insights
Arsenic exposure causes chromosomal abnormalities and inhibits human telomerase (hTERT) gene transcription, potentially explaining its dual role as both a cancer treatment and carcinogen.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Arsenic compounds are utilized in treating acute promyelocytic leukemia.
- Arsenic also exhibits carcinogenic properties, presenting a paradoxical effect.
- Understanding arsenic resistance mechanisms in leukemia is crucial.
Purpose of the Study:
- To elucidate the mechanism of arsenic resistance in the NB4 leukemia cell line.
- To investigate the impact of arsenic exposure on chromosomal stability and telomerase activity.
- To explain the paradoxical carcinogenic and antitumor effects of arsenic.
Main Methods:
- Exposure of NB4 leukemia cells to arsenic.
- Analysis of chromosomal abnormalities, specifically end-to-end fusions.
- Assessment of human telomerase reverse transcriptase (hTERT) gene transcription.
- Evaluation of c-Myc and Sp1 transcription factor activities.
Main Results:
- Arsenic exposure induced chromosomal abnormalities, predominantly end-to-end fusions.
- Arsenic was found to inhibit hTERT gene transcription.
- Decreased activity of c-Myc and Sp1 transcription factors was observed.
- Inhibition of telomerase activity leads to chromosomal end lesions.
Conclusions:
- Arsenic-induced inhibition of human telomerase (hTERT) transcription, possibly via reduced c-Myc and Sp1 activity, contributes to chromosomal instability.
- This chromosomal instability may drive either cancer cell death or genomic instability and carcinogenesis.
- The findings provide a molecular basis for arsenic's dual role in cancer therapy and carcinogenesis.
More Related Videos
08:34Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
09:13Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells
Published on: January 17, 2019
Related Concept Videos
Telomeres and Telomerase
Replicative Cell Senescence
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Telomeres and Telomerase
Mutagenicity and Carcinogenicity
Spontaneous and Induced Mutations